Table 2.
Comparison between COVID-19 and non-COVID-19 acute stroke patients when the stay-at-home order was placed during the COVID-19 pandemic
| Non-COVID-19 group | COVID-19 group | p value | |
|---|---|---|---|
| Mean age, years | 63.5 | 72.5 | 0.058 |
| Sex | 0.164 | ||
| Male | 20/36 (55.6%) | 9/11 (81.8%) | |
| Female | 16/36 (44.4%) | 2/11 (18.2%) | |
| Stroke risk factors | |||
| Hypertension | 26/36 (72.2%) | 9/11 (81.8%) | 0.703 |
| Diabetes mellitus | 12/36 (33.3%) | 2/11 (18.2%) | 0.464 |
| Atrial fibrillation | 5/36 (13.9%) | 7/11 (63.3%) | 0.003 |
| Smoking history | 10/36 (27.8%) | 1/11 (9.1%) | 0.525 |
| Low-density lipoprotein notable | 16/36 (44.4%) | 9/11 (81.8%) | 0.041 |
| A history of prior stroke | 10/36 (27.8%) | 2/11 (18.2%) | 0.703 |
| Stroke subtype | |||
| Ischemic stroke | 27/36 (75%) | 10/11 (90.9%) | 0.413 |
| Hemorrhagic stroke | 8/36 (22.2%) | 1/11 (9.1%) | 0.663 |
| Initial NIHSS score | 0.229 | ||
| 0–4 | 12/27 (44.4%) | 3/9 (33.3%) | |
| 5–15 | 11/27 (40.7%) | 2/9 (22.2%) | |
| 16–20 | 2/27 (7.4%) | 3/9 (33.3%) | |
| 21–42 | 2/27 (7.4%) | 1/9 (11.1%) | |
| Difference in LKW and ED time | 0.855 | ||
| <4.5 h | 15/27 (55.6%) | 4/9 (44.4%) | |
| 4.5–12 h | 2/27 (7.4%) | 0/9 (0%) | |
| 12–24 h | 7/27 (25.9%) | 4/9 (44.4%) | |
| >24 h | 3/27 (11.1) | 1/9 (11.1%) | |
| Administration of tPA | 10/36 (27.8%) | 4/11 (36.4%) | 0.710 |
| Large vessel occlusion | 12/36 (33.3%) | 4/11 (36.4%) | >0.999 |
| Mechanical thrombectomy | 11/36 (30.6%) | 3/11 (27.3%) | >0.999 |
Values express n, unless otherwise indicated. COVID-19, 2019-novel Coronavirus; NIHSS, National Institutes of Health Stroke Scale; LKW, last known well; ED, emergency department; tPA, tissue plasminogen activator.